Is penny stock Cineworld a cheap buy at under 4p?

The Cineworld share price has been in freefall since the pandemic decimated the cinema sector. Is this penny stock now a cheap buy at under 4p?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

A man with Down's syndrome serves a customer a pint of beer in a pub.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Cineworld (LSE: CINE) share price has plummeted in recent years to less than 4p. That’s a startling 88% drop from where it stood even at the beginning of 2022 and a catastrophic fall of 99% from its pre-pandemic price. 

Does this massive drop make this penny stock a cheap buy or are we looking at a dangerous value trap? I think the answer starts with decisions made even before the pandemic threw a spanner in the works for the cinema sector.

Cineworld amassed an eye-watering debt

Cineworld management spent the years leading up to the pandemic amassing debt in questionable acquisitions. 

Before Covid-19, Cineworld made a number of questionable acquisitions. One example that becomes important later was the botched $2.1bn takeover of Canadian rival Cineplex in December 2019.

One analyst criticised the management’s attempts to “build an empire in a sunset industry”. Whether you believe the cinema sector is a dying industry or not, the company built up debt like it was going out of style.

So when the coronavirus kept the world in their homes and away from movie theatres, Cineworld and its competitors like Vue and AMC struggled desperately, having little else to sell apart from overpriced popcorn.

And the knockout punch? As pandemic restrictions were lifted, ticket sales and revenue did not return to previous levels. 

20182019202020212022 (6 months)
Admissions273m275m54m95m83m
Revenue$4.1bn$4.4bn$0.9bn$1.8bn$1.5bn

This slower-than-expected recovery caused Cineworld to apply for bankruptcy in the US and sent the share price into a tailspin. The market cap now stands at a sorry £58m. 

Some good news? Those revenues are extremely high compared to that market cap, and I see two potential ways out for the firm and its beleaguered shareholders.

The cinema operator has two ways out

The first potential lifeline for Cineworld would be a takeover. The bankruptcy proceedings issued a final date 16 February for suitors to establish their interest, so news should be released soon. Rumours have circulated that both Vue and AMC are interested.

The danger here is that any takeover is unlikely to provide a big win for shareholders. In fact, communications from administrators have indicated that investments are likely to be significantly diluted in the event of a restructuring or sale. 

Another possibility is simply a long road to recovery. How likely is this? Well, the latest earnings revealed an operating profit of $57.3m in the first six months of 2022. So that’s a step in the right direction, but it’s a fraction of the financing costs for the same period of $409m. 

Not only that, but Cineworld doesn’t expect admissions figures to return to previous levels in either full year 2023 or 2024. It might be a long wait before the company can even afford to service its debt. 

Oh, and that takeover of Cineplex? The Canadian firm was awarded $1.2bn in damages to be paid by Cineworld after they pulled out of the deal. 

All being said, if cinema goers returned to pre-pandemic levels and Cineworld can weather the storm until then, investors might find value here. A high-risk, high-reward play, and one with just too much risk for me to be interested in buying.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

John Fieldsend has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up of British bank notes
Investing Articles

£8 per year in extra income for life, for each £100 invested today? Here’s how!

Christopher Ruane explains how he would aim to set up extra income streams for the rest of his life by…

Read more »

Photo of a man going through financial problems
Investing Articles

With a £20K Stocks and Shares ISA, I’d target £1,964 in annual dividends like this

With an annual passive income target close to £2,000, our writer explains how he'd put a £20K Stocks and Shares…

Read more »

Illustration of flames over a black background
Investing Articles

Down 63% in 2024, what’s going on with the Avacta (AVCT) share price?

2024 has been a difficult year for many companies in the biotechnology sector, with the AVCT share price down heavily.…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Here’s how I’d invest £800 the Warren Buffett way!

Christopher Ruane learns some lessons from super-investor Warren Buffett he hopes could improve his own stock market performance.

Read more »

British Isles on nautical map
Investing Articles

Michael Burry just bought 175,000 shares in this FTSE 100 company

Scion Asset Management announced a $6.5bn stake in BP this week. But what could Michael Burry be seeing in an…

Read more »

Young Asian woman holding a cup of takeaway coffee and folders containing paperwork, on her way into the office
Investing Articles

£5,000 in savings? Here’s how I’d aim to start making powerful passive income today

With a cash lump sum to invest, this Fool lays out how he'd start making passive income. He also details…

Read more »

Investing Articles

Just released: our 3 top small-cap stocks to consider buying before June [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

My best FTSE 250 stock to consider buying now for passive income while it’s near 168p

This is a rare stock with a growing underlying business and a fat dividend yield – it’s worth consideration for…

Read more »